Live Quote · NASDAQINCYHealthcare· Biotechnology

Incyte Corporation

$114.63▼ 1.07%($-1.25)
MKT CAP $23.36BNEXT EARNINGS Feb 9, 2027
50%
Bullish
TickerSpark Score
78/100
▌ Solid
60
Valuation
75
Profitability
95
Growth
100
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INCY research report →

Analyst Price Target
$136.47+19.1% vs. today

Range $104 – $157

Analyst RatingBuy
24 Buy20 Hold1 Sell

Price Chart

+14.36% · this period
$129.93$110.12$90.30Nov 19May 22Nov 19
52-Week Range59% of range
Low
$89.25
Current
$114.63
High
$132.60

AI analysis · Last refreshed November 16, 2026 · Live quote · Not investment advice